SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-227707
Filing Date
2009-11-06
Accepted
2009-11-06 17:03:48
Documents
7
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 406361
2 FIRST AMENDMENT OF THE LICENSE AGREEMENT, DATED NOVEMBER 9, 2007 dex101.htm EX-10.1 15334
3 SECOND AMENDMENT OF THE LICENSE AGREEMENT, DATED SEPTEMBER 25, 2009 dex102.htm EX-10.2 20543
4 THIRD AMENDMENT TO THE LICENSE AGREEMENT, DATED OCTOBER 2, 2009 dex103.htm EX-10.3 764467
5 RULE 13A-14(A) CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 9416
6 RULE 13A-14(A) CERTIFICATION BY PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER dex312.htm EX-31.2 9417
7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3482
  Complete submission text file 0001193125-09-227707.txt   1230460
Mailing Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804
Business Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 091165509
SIC: 2836 Biological Products, (No Diagnostic Substances)